(0.31%) 5 115.54 points
(0.23%) 38 329 points
(0.33%) 15 981 points
(-1.11%) $82.92
(4.99%) $2.02
(0.17%) $2 351.20
(0.42%) $27.65
(3.75%) $956.70
(-0.23%) $0.933
(-0.34%) $10.99
(-0.55%) $0.796
(1.65%) $93.39
0.00% $ 0.870
Live Chart Being Loaded With Signals
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases...
Stats | |
---|---|
Volumen de hoy | 941 412 |
Volumen promedio | 1.38M |
Capitalización de mercado | 0.00 |
EPS | $0 ( 2022-04-05 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.227 |
ATR14 | $0.157 (18.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2005-04-18 | Orbimed Advisors Llc | Buy | 0 | Not reporting securities information. |
2004-06-30 | Stahl Pamela J | Buy | 17 500 | Stock Option (Right to Buy) |
2004-06-15 | Champsi Farah | Buy | 5 000 | Non-employee Director Stock Options (Right to Buy) |
2004-06-15 | Vida Julius A | Buy | 5 000 | Non-employee Director Stock Option (Right to Buy) |
INSIDER POWER |
---|
0.00 |
Last 3 transactions |
Buy: 27 500 | Sell: 0 |
Volumen Correlación
Orphazyme A/S Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Orphazyme A/S Correlación - Moneda/Commodity
Orphazyme A/S Finanzas
Annual | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-22.32 |
FY | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-22.32 |
FY | 2019 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-16.87 |
FY | 2018 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-11.50 |
Financial Reports:
No articles found.
Orphazyme A/S
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico